CHARLESTON, S.C., April 20, 2012 (GLOBE NEWSWIRE) -- Revolutions Medical Corporation (“Revolutions Medical” or the “Company”) (OTCQB:RMCP) announced today that the Israeli Ministry of Health (IMH) has approved the RevVac™ safety syringe for sale and distribution by registering the product in its catalog of approved medical devices. Now that the RevVac™ safety syringe has been licensed in Israel, the Company’s exclusive distributor in that country, CeifiT, Ltd. (“CeifiT”), may now accept and fulfill orders from Israel’s four national medical centers. The Company is now also permitted to supply the syringes previously pledged to support the IMH’s Izhar Project to combat the re-use of contaminated needles.
